Cas:118754-55-5 2-bromo-1,3-dichloro-5-(trifluoromethoxy)benzene manufacturer & supplier

We serve Chemical Name:2-bromo-1,3-dichloro-5-(trifluoromethoxy)benzene CAS:118754-55-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-bromo-1,3-dichloro-5-(trifluoromethoxy)benzene

Chemical Name:2-bromo-1,3-dichloro-5-(trifluoromethoxy)benzene
CAS.NO:118754-55-5
Synonyms:2,5-DIBROMO-1,4-BENZOQUINONE;2,6-DICHLORO-4-(TRIFLUOROMETHOXY)BROMOBENZENE;Benzene,2-bromo-1,3-dichloro-5-(trifluoromethoxy)
Molecular Formula:C7H2BrCl2F3O
Molecular Weight:309.89500
HS Code:2909309090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:9.23000
Exact Mass:307.86200
LogP:4.65450

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2,5-DIBROMO-1,4-BENZOQUINONE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzene,2-bromo-1,3-dichloro-5-(trifluoromethoxy) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,5-DIBROMO-1,4-BENZOQUINONE Use and application,2,6-DICHLORO-4-(TRIFLUOROMETHOXY)BROMOBENZENE technical grade,usp/ep/jp grade.


Related News: There are limited treatment options for the disorder. Women with advanced endometrial cancer who are not candidates for curative therapy have a survival rate of just 17% (2S,5S)-5-hydroxy-7-(p-methoxybenzyloxy)-2-methyl-1-(triisopropylsiloxy)-heptan-3-one manufacturers Wavelength’s growth in the API space comes as nations around the world look to develop redundant supply chains for key generic medicines amid the pandemic. N4-(3-(isopropylamino)-4-methylphenyl)-N6,N6-dimethyl-2-(4-(pyridin-2-yl)piperazin-1-yl)pyrimidine-4,6-diamine suppliers “This announcement reflects another important regulatory milestone in the development of this medicine,” said Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. dithiophosphoric acid O,S-diethyl ester-S’-(ethylsulfanyl-methyl ester) vendor & factory.